Description | Nervegrowthfactorreceptor(NGFR)isalsoreferredtoasp75(NTR)duetoitsmolecularmassanditsABIlitytobindatlowaffinitynotonlyNGF(see162030),butalsootherneurotrophins,includingbrain-derivedneurotrophicfactor(BDNF;113505),neurotrophin-3(NTF3;162660),andneurotrophin-4/5(NTF5;162662).Atthetimeofitsdiscovery,NGFRwasconsideredauniquetypeofprotein.Subsequently,however,alargesuperfamilyoftumornecrosisfactorreceptorswerefoundtosharetheoverallstructureofNGFR(4extracellularligand-binding,cysteine-richrepeats,orCRs,andsignalingthroughassociationwith,ordisassociationfrom,cytoplasmicinteractors).TheidentificationofthissuperfamilyhelpedelucidatesomeoftheBIOLOGicfunctionsofNGFR,includingitsultimateinvolvementinthenuclearfactorkappa-B(NFKB;see164011)andapoptosispathways.Asamonomer,NGFRbindsNGFwithlowaffinity.Higheraffinitybindingisachievedbyassociationwithhighermolecularmass,low-affinityneurotrophinreceptors,namelythetropomyosinreceptorkinases,TRKA(NTRK1;191315),TRKB(NTRK2;600456),andTRKC(NTRK3;191316).TRKA,TRKB,andTRKCarespecificforor"preferredby"NGF,NTF5andBDNF,andNTF3,respectively.NTF3alsobindstoTRKAandTRKB,butwithsignificantlyloweraffinity. |
Relatedproducts | M-1763-100-FT,Non-specificControlIgG,cloneX63(Monoclonal)-FITC |
BatchNo. | Seeproductlabel |
Unitsize | 100µg |
Antigen | Thep75NTRantibodywasderivedfromimmunizationofmicewithhumanWM245melanomacells. |
Clone | ME20.4 |
OtherNames | Low-affinitynervegrowthfactorreceptor;NGFreceptor;Gp80-LNGFR;p75ICD;Lowaffinityneurotrophinreceptorp75NTR |
Accession | TNR16_HUMAN |
Producedin | Mouse |
Purity | Immunoglobulin(IgG1)waspurifiedusingProteinGcolumn(AmershamPharmacia),polishedwithSephacryl200HR(AmershamPharmacia)inPBS.TheantibodywasthenconjugatedtoFluoresceinisomer1(FITC,Sigma).Aminimumfluorescein:proteinratioof3:1isguaranteed.TheconjugatewaspurifiedviagelfiltrationusingaG25finegraingelin10mMTris/50mMNaClsolution. |
Applications | Thisantibodyisrecommendedforuseinimmunohistochemistry,immunofluorescence,flowcytometryandNGFreceptorp75dynamics.Forimmunohistochemistryaconcentrationof2µg/mlisrecommended.NotappropriateforWesternBlots.ForFACSaconcentrationof20µg/mlisrecommendedandfor1siteELISAatleasta1in5000dilution.Biosensisrecommendsoptimaldilutions/concentrationsshouldbedeterminedbytheenduser. |
Specificity | Thisantibodyrecognisesp75NTR(lowaffinityneurotrophinreceptor) |
Cross-reactivity | Reactswithhuman,cat,dog,pig,rabbitandsheep.Doesnotreactwithratormouse. |
Form | Liquid.10mMTris,50mMNaCl |
Storage | Theantibodyconjugatecanbestoredat4ºCforupto4monthswiththeadditionofappropriateantibacterialagent. |
ExpiryDate | Fourmonthsafterpurchase |
References | 1.WalkerBRetal.(2007)BehavBrainRes176:109-20 2.RossA.H.etal.(1984)Characterizationofnervegrowthfactorreceptorinneuralcresttumorsusingmonoclonalantibodies.ProcNatlAcadSciUSA.1984Nov;81(21):6681-5.ORIGINALPAPER |
Biosensis专注于神经科学领域的抗体和试剂的开发,特别是神经营养因子和神经营养因子受体。 近30年来,Biosensis一直是该领域的全球领航者和OEM供应商。除神经营养因子,我们的神经科学产品组合还被广泛用于神经退行性疾病、神经发育和神经代谢的研究。重点研究领域包括阿尔茨海默氏症(AD)、帕金森氏症(PD)和肌萎缩侧索硬化(ALS)疾病,以及自噬和代谢应激障碍,包括肥胖、代谢综合征的研究、神经免疫学和炎症。